Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
David H. Rosmarin brings a founder-focused approach to anxiety at TechCrunch All Stage

From TechCrunch

By TechCrunch Events

July 2, 2025

David H. Rosmarin brings a founder-focused approach to anxiety at TechCrunch All Stage

Startups demand constant decision-making and pressure-filled pivots, which bring big emotional swings. It’s no wonder anxiety shows up at every stage. But what if it didn’t have to be a liability? At TechCrunch All Stage 2025 on July 15 at Boston’s SoWa Power Station, Dr. David H. Rosmarin, clinical psychologist, author, and Harvard Medical School […]

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

TechCrunch All Stage: Full agenda revealed

TechCrunch All Stage: Full agenda revealed

The full agenda revealed for TechCrunch All Stage, featuring VC leaders from Precursor Ventures, CapitalG, and more. July 15 in Boston. Register now to save $210.

Apr 16, 2025

Final day to submit your speaker application and shape the next wave of startups at TechCrunch All Stage

Final day to submit your speaker application and shape the next wave of startups at TechCrunch All Stage

The application to speak at TechCrunch All Stage closes tonight at 11:59 p.m. PT. This is your last chance to share insights with 1,200+ founders and VCs. Apply here.

Apr 18, 2025

Kristen Craft brings fresh fundraising strategy to the Foundation Stage at
TechCrunch All Stage

Kristen Craft brings fresh fundraising strategy to the Foundation Stage at TechCrunch All Stage

At TechCrunch All Stage on July 15 at Boston’s SoWa Power Station, Kristen Craft, Head of Business Development at Fidelity Private Shares, will lead a roundtable session titled “It’s Not 2021 Anymore. Navigating the 2025 VC Landscape.”

Jul 3, 2025

Jon McNeill brings the operator’s playbook to TechCrunch All Stage

Jon McNeill brings the operator’s playbook to TechCrunch All Stage

At TechCrunch All Stage 2025, Jon McNeill, CEO and co-founder of DVx Ventures, will take the Scale Stage to flip the script on conventional startup growth advice.

Jul 1, 2025

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

TechCrunch All Stage: Full agenda revealed

TechCrunch All Stage: Full agenda revealed

The full agenda revealed for TechCrunch All Stage, featuring VC leaders from Precursor Ventures, CapitalG, and more. July 15 in Boston. Register now to save $210.

Apr 16, 2025

Final day to submit your speaker application and shape the next wave of startups at TechCrunch All Stage

Final day to submit your speaker application and shape the next wave of startups at TechCrunch All Stage

The application to speak at TechCrunch All Stage closes tonight at 11:59 p.m. PT. This is your last chance to share insights with 1,200+ founders and VCs. Apply here.

Apr 18, 2025

Kristen Craft brings fresh fundraising strategy to the Foundation Stage at
TechCrunch All Stage

Kristen Craft brings fresh fundraising strategy to the Foundation Stage at TechCrunch All Stage

At TechCrunch All Stage on July 15 at Boston’s SoWa Power Station, Kristen Craft, Head of Business Development at Fidelity Private Shares, will lead a roundtable session titled “It’s Not 2021 Anymore. Navigating the 2025 VC Landscape.”

Jul 3, 2025

Jon McNeill brings the operator’s playbook to TechCrunch All Stage

Jon McNeill brings the operator’s playbook to TechCrunch All Stage

At TechCrunch All Stage 2025, Jon McNeill, CEO and co-founder of DVx Ventures, will take the Scale Stage to flip the script on conventional startup growth advice.

Jul 1, 2025